tradingkey.logo

ADC Therapeutics Announces Amended Healthcare Royalty Financing Agreement

ReutersFeb 23, 2026 12:28 PM

- ADC Therapeutics SA ADCT.N:

  • ADC THERAPEUTICS ANNOUNCES AMENDED HEALTHCARE ROYALTY FINANCING AGREEMENT

  • ADC THERAPEUTICS SA - AGREEMENT REDUCES CHANGE OF CONTROL PAYMENT TO $150 MILLION THROUGH 2027

  • ADC THERAPEUTICS SA - HEALTHCARE ROYALTY GRANTED WARRANTS TO PURCHASE ABOUT 9.8 MILLION COMMON SHARES, WITH EXERCISE PRICE OF $3.81 PER SHARE

  • ADC THERAPEUTICS SA - ANTICIPATE MEANINGFUL GROWTH BEGINNING 2027, POTENTIAL PEAK REVENUE IN US COULD REACH $600 MILLION TO $1 BILLION ANNUALLY

  • ADC THERAPEUTICS SA - IN EVENT OF CHANGE OF CONTROL, HEALTHCARE ROYALTY WILL CONTINUE TO RECEIVE ROYALTIES BY ACQUIRER UNTIL ORIGINAL CAP IS REACHED

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI